Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension
Authors:
- B. SztrymfBSB. Sztrymf
- R. SouzaRSR. Souza
- L. BertolettiLBL. Bertoletti
- X. JaïsXJX. Jaïs
- O. SitbonOSO. Sitbon
- L. C. PriceLPL. C. Price
- G. SimonneauGSG. Simonneau
- M. HumbertMHM. Humbert
- 6 November 2009
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 35 (6) , 1286-1293
Abstract
Acute right ventricular failure in the setting of pulmonary arterial hypertension (PAH) often requires hospitalisation in intensive care units (ICU) to manage the subsequent low cardiac output and its consequences. There are very few data on these acute events.We recorded demographic, clinical and biological data and therapy in consecutive patients suffering from acute right heart failure requiring catecholamine treatment in the ICU of the French referral centre for pulmonary hypertension. These variables were analysed according to the survival status in ICU.46 patients were included, the mean age was 50.3 yrs. ICU mortality was 41%. We found no difference in terms of demographics, clinical data, last haemodynamic measurements at admission. Systemic arterial pressure was significantly lower in the subgroup of patients whose clinical course was fatal. Plasma brain natriuretic peptide (BNP), C-reactive protein (CRP), serum sodium and creatinine at admission correlated with survival. Demonstration of an infection during the ICU stay was associated with a worse prognosis.These preliminary results underline the importance of some simple clinical and biological parameters in the prognostic evaluation of acute heart failure in the setting of PAH. Whether these parameters can guide therapy needs to be further investigated.Keywords
This publication has 39 references indexed in Scilit:
- Antithrombotic Therapy for Venous Thromboembolic DiseaseChest, 2008
- Pulmonary Arterial HypertensionJACC, 2008
- Management strategies for patients with pulmonary hypertension in the intensive care unit*Critical Care Medicine, 2007
- Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure*Critical Care Medicine, 2006
- The Acutely Decompensated Right VentricleChest, 2005
- Introduction: new insights into a challenging diseaseJACC, 2004
- Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure*Critical Care Medicine, 2004
- The pulmonary physician in critical care * 13: The pulmonary circulation and right ventricular failure in the ITUThorax, 2003
- A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter StudyJAMA, 1993
- Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.Circulation, 1978